AMEX (USD): NovaBay Pharmaceuticals, Inc. (NBY)
Last Price
0.86
Today's Change
+0.363 (73.03%)
Day's Change
0.616 - 0.94
Trading Volume
129,591,429
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
World to Pay to Turn Off Green Power Unless Grids Improve
2
US Housing Starts Increase to Fastest Pace Since April
3
Elon Musk’s X Bypasses Brazil Ban Through Software Update
4
US Mortgage Rates Drop to Two-year Low Ahead of US Fed Rate Cut
5
BofA Now Expects US Fed to Go for 75-bp Cut in 4Q After Bumper Rate Reduction
#
Stock
Score
ZEO
Zeo Energy Corp.
GOOGL
Alphabet Inc.
833
AGN
666
PLTR
Palantir Technologies Inc.
566
BABA
Alibaba Group Holding Limited
6
AAPL
Apple Inc.
500
7
FB
400
8
BAC
Bank of America Corporation
333
9
CBM
10
ALAI
Alger AI Enablers & Adopters ETF
Last
Change
Volume
XPON
0.084
+0.026
1,427,558,764
NVDA
116.47
-1.397
213,364,532
VERB
0.069
+0.013
155,256,424
CERO
0.121
+0.034
147,228,823
NBY
+0.363
SQQQ
7.82
+0.064
129,110,447
LMDX
0.016
-0.018
120,553,903
SOXL
33.38
-1.735
91,683,485
INTC
22.09
+0.95
85,994,347
762.00
-84.71
85,558,284
CEG
252.45
+43.95
11,591,439
BKNG
4,044.93
+27.42
194,197
RYVLX
530.29
+25.87
0
RYVYX
530.12
+25.86
TPL
938.82
+23.16
73,466
FCNCA
1,960.86
+21.29
72,662
CRWD
297.89
+20.51
8,333,562
RYCCX
381.75
+18.62
NOW
936.95
+17.70
1,064,431
MOG-B
203.00
+16.48
206
BRK-A
682,955.52
-4,884.437
1,318
MELI
1,629.32
-188.66
1,851,535
NVR
9,500.00
-159.65
11,847
MSTR
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....